Dd-cfDNA was similarly found to be elevated with AMR, with median levels of 1.34%, compared with stable patients (0.38%), in a study utilizing 107 archived biorepository plasma samples from 38 patients, though this small sample size study did not reach statistical significance ( 37 ).
← all excerpts
Using a combination of biomarkers to monitor allograft dysfunction in lung transplant recipients.
1
—
—